Use of skin substitute dressings in the treatment of staphylococcal scalded skin syndrome in neonates and young infants

13Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Staphylococcal scalded skin syndrome (SSSS) is a rare toxin-mediated skin disease caused by Staphylococcus aureus and seen in infants and children younger than 5 years. Objectives: The supportive role of skin substitutes in SSSS is stressed as a new and relatively unknown method. Methods: Retrospective observational case-series study, in neonates and young infants diagnosed with SSSS. Results: Seven infants with SSSS, treatment with antibiotics, skin substitutes, strict pain relief strategy and prognosis were described. One of them was severely affected and deceased. Conclusion: This study describes 7 infants with SSSS and stresses the important role of skin substitutes as Omiderm® and Suprathel® as valuable adjuvant treatment modality. Copyright © 2010 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Baartmans, M. G. A., Dokter, J., Den Hollander, J. C., Kroon, A. A., & Oranje, A. P. (2011). Use of skin substitute dressings in the treatment of staphylococcal scalded skin syndrome in neonates and young infants. Neonatology, 100(1), 9–13. https://doi.org/10.1159/000317997

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free